The effect of omega-3 fatty acids on central nervous system remyelination in fat-1 mice
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2202
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
The effect of omega-3 fatty acids on central nervous system remyelination in fat-1 mice ; volume:18 ; number:1 ; day:24 ; month:1 ; year:2017 ; pages:1-9 ; date:12.2017
BMC neuroscience ; 18, Heft 1 (24.1.2017), 1-9, 12.2017
- Schlagwort
-
Hirnkrankheit
Neuropsychiatrie
Nervenkrankheit
- Urheber
-
Siegert, Elise
- Beteiligte Personen und Organisationen
-
Paul, Friedemann
Rothe, Michael
Weylandt, Karsten H.
SpringerLink (Online service)
- DOI
-
10.1186/s12868-016-0312-5
- URN
-
urn:nbn:de:1111-201702182242
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:58 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Siegert, Elise
- Paul, Friedemann
- Rothe, Michael
- Weylandt, Karsten H.
- SpringerLink (Online service)
Ähnliche Objekte (12)
The German healthcare system
The implication of natural killer cells and neutrophils in autoimmune disorders of the central nervous system
Vitamin D in the prevention, prediction and treatment of neurodegenerative and neuroinflammatory diseases
Can we prevent or treat multiple sclerosis by individualised vitamin D supply?
An attempt to explain the neurological symptoms of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Correction to: An attempt to explain the neurological symptoms of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Optical coherence tomography in neuromyelitis optica spectrum disorders: potential advantages for individualized monitoring of progression and therapy
Langfristige Therapie mit Interferon-β 1a subkutan: Klinischer Verlauf und Genexpressionsveränderungen im Blut von Patienten mit schubförmig verlaufender Multipler Sklerose
Exercise in multiple sclerosis -- an integral component of disease management
Efficacy of Vitamin D Supplementation in Multiple Sclerosis (EVIDIMS Trial): study protocol for a randomized controlled trial
The Berlin Treatment Algorithm: recommendations for tailored innovative therapeutic strategies for multiple sclerosis-related fatigue
Systemic TLR2 tolerance enhances central nervous system remyelination
The German healthcare system
The implication of natural killer cells and neutrophils in autoimmune disorders of the central nervous system
Vitamin D in the prevention, prediction and treatment of neurodegenerative and neuroinflammatory diseases
Can we prevent or treat multiple sclerosis by individualised vitamin D supply?
An attempt to explain the neurological symptoms of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Correction to: An attempt to explain the neurological symptoms of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Optical coherence tomography in neuromyelitis optica spectrum disorders: potential advantages for individualized monitoring of progression and therapy
Langfristige Therapie mit Interferon-β 1a subkutan: Klinischer Verlauf und Genexpressionsveränderungen im Blut von Patienten mit schubförmig verlaufender Multipler Sklerose
Exercise in multiple sclerosis -- an integral component of disease management
Efficacy of Vitamin D Supplementation in Multiple Sclerosis (EVIDIMS Trial): study protocol for a randomized controlled trial
The Berlin Treatment Algorithm: recommendations for tailored innovative therapeutic strategies for multiple sclerosis-related fatigue
Systemic TLR2 tolerance enhances central nervous system remyelination
The German healthcare system
The implication of natural killer cells and neutrophils in autoimmune disorders of the central nervous system
Vitamin D in the prevention, prediction and treatment of neurodegenerative and neuroinflammatory diseases
Can we prevent or treat multiple sclerosis by individualised vitamin D supply?
An attempt to explain the neurological symptoms of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Correction to: An attempt to explain the neurological symptoms of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Optical coherence tomography in neuromyelitis optica spectrum disorders: potential advantages for individualized monitoring of progression and therapy
Langfristige Therapie mit Interferon-β 1a subkutan: Klinischer Verlauf und Genexpressionsveränderungen im Blut von Patienten mit schubförmig verlaufender Multipler Sklerose
Exercise in multiple sclerosis -- an integral component of disease management
Efficacy of Vitamin D Supplementation in Multiple Sclerosis (EVIDIMS Trial): study protocol for a randomized controlled trial
The Berlin Treatment Algorithm: recommendations for tailored innovative therapeutic strategies for multiple sclerosis-related fatigue